Reading is good for you...
Reading about what's good for you is even better.

August 8, 2022

August 10, 2022

August 2, 2022
Prescription required
Get your Victoza delivered at your door for FREE
Available Form:
INJ.PEN
Manufacturer name:
Novo Nordisk
Generic name:
LIRAGLUTIDE
Strength:
18MG/3ML
Victoza (Liraglutide) belongs to a group of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. It is used along with other medications by adults and children older than 10 years of age, to improve blood glucose (sugar) levels for people with Type 2 Diabetes.
Get Victoza delivered for free
Save time. Skip the line. Join Pocketpills and fill your prescriptions online.
Insurance coverage
We accept all insurance plans
Estimated copay
$98.28
Drug cost
$478.43
Dispensing fee
$12.99
Delivery cost
FREE
Insurance coverage
$393.14
**Actual price will depend on the insurance coverage in your province
Victoza (Liraglutide) belongs to a group of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. It is used along with other medications by adults and children older than 10 years of age, to improve blood glucose (sugar) levels for people with Type 2 Diabetes. It works by helping your body make more insulin and control blood glucose levels.
Victoza (Liraglutide) is also used for people with type 2 diabetes who also have cardiovascular disease. It is used in addition to diet, exercise, and other medications to reduce the risk of dying from cardiac disease.
Victoza (Liraglutide) may be available under multiple brand names and/or in several different forms. Any specific brand name of Victoza (Liraglutide) may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of Victoza (Liraglutide) may not be used for all of the conditions discussed here.
Your doctor may have suggested Victoza (Liraglutide) for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are being given Victoza (Liraglutide), speak to your doctor. Do not stop using Victoza (Liraglutide) without consulting your doctor.
Do not give Victoza (Liraglutide) to anyone else, even if they have the same symptoms as you do. It can be harmful for people to use Victoza (Liraglutide) if their doctor has not prescribed it.
The recommended starting dose of Victoza (Liraglutide) is 0.6 mg daily injected subcutaneously (under the skin) on your stomach area (abdomen), upper thigh, or upper arm, exactly as instructed by your doctor or diabetes educator. It can be injected at any time of the day, without regard to meals. After one week, your doctor may increase the dose to 1.2 mg once daily. If needed, your doctor may increase the dose again in one week to 1.8 mg once daily. Do not change your dose unless your doctor has told you to do so.
If you are also using insulin, each medication should be injected separately.
Many things can affect the dose of a medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are using the medication without consulting your doctor.
It is important to take Victoza (Liraglutide) exactly as prescribed by your doctor. If you miss a dose, inject your dose on the next day as usual. Do not inject a double dose or increase your dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.
Victoza (Liraglutide) should be clear and colourless. Do not use Victoza (Liraglutide) if you notice particles or anything unusual in the appearance of the solution.
Store Victoza (Liraglutide) in the refrigerator, do not allow it to freeze, and keep it out of the reach of children. After the first use of the pen, Victoza (Liraglutide) can be stored at room temperature or in the refrigerator for up to 30 days. To protect Victoza (Liraglutide) from light, always keep the pen cap on when you are not using it. Always store Victoza (Liraglutide) without a needle attached to prevent contamination, infection, and leakage.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Victoza (Liraglutide). If you are concerned about side effects, discuss the risks and benefits of Victoza (Liraglutide) with your doctor.
The following side effects have been reported by at least 1% of people taking Victoza (Liraglutide). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of these side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Victoza (Liraglutide).
Each mL of clear, colourless solution contains 6 mg of Victoza (Liraglutide). Nonmedicinal ingredients: disodium phosphate dihydrate, propylene glycol, phenol, and water for injection.
Do not use Victoza (Liraglutide) if you:
There may be an interaction between Victoza (Liraglutide) and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Victoza (Liraglutide). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Victoza (Liraglutide).
Diabetes identification: It is important to either wear a bracelet (or necklace) or carry a card indicating you have diabetes and are taking medication to manage your blood glucose levels.
Heart problems: Victoza (Liraglutide) may increase heart rate and may affect how electrical impulses travel through the heart muscle. If you have heart disease (e.g., recent Heart Attack, Angina, heart failure) or an abnormal heart rhythm (e.g., heart block or fast heart rate), discuss with your doctor how Victoza (Liraglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Victoza (Liraglutide), and whether any special monitoring is needed.
Intestinal problems: The safety and effectiveness of using Victoza (Liraglutide) for people with inflammatory bowel disease (e.g., Crohn's Disease, Ulcerative Colitis) or who have slowed movement through the intestinal tract due to diabetes have not been established. If you have digestive system problems, discuss with your doctor how Victoza (Liraglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Victoza (Liraglutide), and whether any special monitoring is needed.
Kidney function: The safety and effectiveness of using Victoza (Liraglutide) for people with reduced kidney function has not been studied. Ensure that you are drinking enough water to prevent dehydration if you experience nausea or vomiting with Victoza (Liraglutide). If you have reduced kidney function or Kidney Disease, discuss with your doctor how Victoza (Liraglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Victoza (Liraglutide), and whether any special monitoring is needed.
Liver function: The safety and effectiveness of using Victoza (Liraglutide) for people with reduced liver function have not been studied. If you have reduced liver function or liver disease, discuss with your doctor how Victoza (Liraglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Victoza (Liraglutide), and whether any special monitoring is needed.
Low blood glucose (hypoglycemia): People who use Victoza (Liraglutide) and are also taking a sulfonylurea (e.g., Glyburide, Gliclazide) to control high blood sugar are more at risk of experiencing hypoglycemia (low blood sugar). If you experience symptoms of hypoglycemia such as a cold sweat, nervousness or shakiness, fast heartbeat, headache, hunger, confusion, lightheadedness, weakness, and numbness or tingling of the tongue or lips, contact your doctor. Your doctor may need to adjust the dose of your medication(s).
Pancreatitis (inflammation of the pancreas): Victoza (Liraglutide) may cause pancreatitis. If you experience symptoms of pancreatitis such as severe and persistent abdominal pain that may move to the back with or without vomiting, contact your doctor immediately. If you have previously had pancreatitis, discuss with your doctor how Victoza (Liraglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Victoza (Liraglutide), and whether any special monitoring is needed.
Risk of thyroid cancer: In rare cases, people have developed thyroid cancer while using Victoza (Liraglutide). People with a personal or family history of thyroid cancer or people who have multiple endocrine neoplasia syndrome type 2 (a disease where people have tumours in more than one gland in their body) should not use Victoza (Liraglutide). If you develop a lump in your neck or experience difficulty swallowing or breathing, or persistent hoarseness, contact your doctor as soon as possible.
Pregnancy: Victoza (Liraglutide) has not been studied for use by pregnant women and should not be used during pregnancy. If you become pregnant while using Victoza (Liraglutide), contact your doctor immediately.
Breast-feeding: It is not known if Victoza (Liraglutide) passes into breast milk. If you are a breast-feeding mother and are taking Victoza (Liraglutide), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Victoza (Liraglutide) have not been established for children younger than 10 years of age.
Seniors: Seniors may be more likely to experience side effects associated with Victoza (Liraglutide).
References
All material © 1996-2021 MediResource Inc. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.
August 8, 2022
August 10, 2022
August 2, 2022